Dry Powder Formulation of Simvastatin Nanoparticles for Potential Application in Pulmonary Arterial Hypertension

Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry

(2020) Marius M. Hoeper et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Formulation and evaluation of simvastatin polymeric nanoparticles loaded in hydrogel for optimum wound healing purpose

(2019) Usama Farghaly Aly et al.   Drug Design Development and Therapy

A review on the angle of repose of granular materials

(2018) Hamzah M. Beakawi Al-Hashemi et al.   POWDER TECHNOLOGY

Applications of nanoparticle systems in drug delivery technology

(2018) Syed A.A. Rizvi et al.   SAUDI PHARMACEUTICAL JOURNAL

Efficacy and Safety of Statins for Pulmonary Hypertension: A Meta-Analysis of Randomised Controlled Trials

(2017) Yitao Zhang et al.   Heart Lung and Circulation

Physical characterization of nanoparticle size and surface modification using particle scattering diffusometry

(2016) Katherine N. Clayton et al.   Biomicrofluidics

Large Porous Hollow Particles: Lightweight Champions of Pulmonary Drug Delivery

(2016) Sachin Gharse et al.   CURRENT PHARMACEUTICAL DESIGN

Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate

(2016) Alice Simon et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Influence of physical properties of carrier on the performance of dry powder inhalers

(2016) Tingting Peng et al.   Acta Pharmaceutica Sinica B

Nanoparticle interaction with the immune system / Interakcije nanodelcev z imunskim sistemom

(2015) Veno Kononenko et al.   Arhiv za Higijenu Rada i Toksikologiju-Archives of Industrial Hygiene and Toxicology

Challenges in the Treatment of Chronic Wounds

(2015) Robert G. Frykberg et al.   Advances in Wound Care

Novel Simvastatin Inhalation Formulation and Characterisation

(2014) Alaa S. Tulbah et al.   AAPS PHARMSCITECH

Effect of Sampling Volume on Dry Powder Inhaler (DPI)-Emitted Aerosol Aerodynamic Particle Size Distributions (APSDs) Measured by the Next-Generation Pharmaceutical Impactor (NGI) and the Andersen Eight-Stage Cascade Impactor (ACI)

(2012) Hlack Mohammed et al.   AAPS PHARMSCITECH

Dry Powder Inhalers: Study of the Parameters Influencing Adhesion and Dispersion of Fluticasone Propionate

(2012) V. N. P. Le et al.   AAPS PHARMSCITECH

Simvastatin as a Treatment for Pulmonary Hypertension Trial

(2010) M. R. Wilkins et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Measuring charge and mass distributions in dry powder inhalers using the electrical Next Generation Impactor (eNGI)

(2009) Susan Hoe et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES